ARCHIVES

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 03 | January 17, 2003

Download PDF Visit The Full Archive

Related Articles

HHS Back down, Says Now It Will Support Survey Of Research Facilities

October 28, 1983

NCI Bypass Budget Seeks $3.64 Billion

January 20, 1995

Children With Recurrent Hodgkin’s Respond To Gemcitabine, Vinorelbine

March 27, 2009

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

UICC Seeks Nominations for Mucio Athayde Prize.

January 7, 2000

NCI Plans Two New RFAs For Stimulus Funds

March 6, 2009